Regulatory & Safety

Regulatory & Safety

Safety, Ethics & Compliance First

Genova Biologix Regulatory

The Highest Standard of Safety & Quality

At Genova Biologix, safety is not a checkbox — it is the foundation on which every product is built. From the moment a donor consents to umbilical cord tissue donation through the final release of a finished product, every step in our supply chain is governed by stringent protocols designed to protect patients, support clinicians, and uphold the integrity of regenerative medicine.


Our manufacturing facility is FDA-registered and fully compliant with all applicable federal regulations. We do not cut corners. We do not compromise. Every vial that leaves our facility has been processed, tested, and validated to meet the most demanding quality standards in the industry.

Manufactured to the Strictest Standards

🏭
cGMP Compliant Manufacturing
All Genova Biologix products are manufactured in full compliance with FDA Current Good Manufacturing Practice (cGMP) regulations — the gold standard for pharmaceutical and biologic production. Our facility undergoes regular audits to ensure continuous compliance.
🧬
cGTP Tissue Practice Standards
We adhere strictly to FDA Current Good Tissue Practice (cGTP) guidelines — the regulatory framework governing the processing, storage, and distribution of human cells, tissues, and cellular products. Every tissue lot is traceable from donor to delivery.
🏆
AATB Accreditation Standards
Our laboratory operations follow the guidelines established by the American Association of Tissue Banks (AATB) — the leading accreditation body for human tissue banking. AATB standards govern donor screening, recovery, processing, and distribution practices.
📋
HCT/P Regulatory Framework
All products are regulated under 21 C.F.R. Part 1271 as Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) and are intended for homologous use only — meaning they are used in a manner consistent with their natural function in the donor body.
🧪
Rigorous Donor Screening
Every donor undergoes comprehensive medical screening in accordance with FDA requirements and AATB standards. Only tissue from donors who meet all eligibility criteria is accepted into our manufacturing pipeline — ensuring the safety and quality of every finished product.
❄️
Single-Dose Cold Chain Delivery
To preserve maximum potency and biological integrity, all Genova Biologix products are shipped in single-dose preparations on dry ice with temperature monitoring throughout transit. Standardized concentrations ensure physicians can accurately measure and administer consistent treatment doses.

What This Means for Your Patients

Our uncompromising approach to safety and quality translates directly into better outcomes for the patients you serve. When you choose Genova Biologix, you are choosing a product partner whose standards are as high as your own.


  • Access to the regenerative capabilities of umbilical cord-derived growth factors and cytokines — the most potent available source
  • Minimally invasive therapy that may reduce or eliminate the need for surgical intervention
  • Potential relief from chronic conditions including joint injuries, arthritis, autoimmune disease, and cardiovascular conditions
  • Consistent, standardized dosing that gives clinicians confidence in treatment planning and reproducibility

Regulatory Disclosure

Genova Biologix products are regulated under 21 C.F.R. Part 1271 and are intended for homologous use only. While produced in an FDA-compliant laboratory, they have not been approved by the FDA for treatment effectiveness.

The FDA states: "FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells for certain indications."

Patients interested in regenerative therapy should consult a physician about FDA approval status and eligibility for clinical trials.

Safety and transparency are the cornerstones of everything we do. Ready to learn how Genova Biologix can elevate your practice?

Contact Us